LAURA SCHULTE: Open Payments
NPI 1770923823 · FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$553 in 15 payments from 7 companies in 2025. Trend: 2023 $251 · 2024 $431 · 2025 $553
Food & beverage: $553
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 2 | $176 |
| Regeneron Healthcare Solutions, Inc. | 1 | $106 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $86 |
| E.R. Squibb & Sons, L.L.C. | 3 | $65 |
| PFIZER INC. | 3 | $63 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| Amgen Inc. | 1 | $19 |
Products named: WATCHMAN FLX, ELIQUIS, EVKEEZA, JARDIANCE, Kerendia, REPATHA.
Industry payments across MD — which companies pay providers there.
